NO904378D0 - Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse. - Google Patents
Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.Info
- Publication number
- NO904378D0 NO904378D0 NO904378A NO904378A NO904378D0 NO 904378 D0 NO904378 D0 NO 904378D0 NO 904378 A NO904378 A NO 904378A NO 904378 A NO904378 A NO 904378A NO 904378 D0 NO904378 D0 NO 904378D0
- Authority
- NO
- Norway
- Prior art keywords
- modified protein
- procedure
- preparation
- therapeutic use
- protein
- Prior art date
Links
- 102000035118 modified proteins Human genes 0.000 title 1
- 108091005573 modified proteins Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 125000003172 aldehyde group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2081163A JP2975632B2 (ja) | 1990-03-30 | 1990-03-30 | グリコサミノグリカン修飾プロテイン |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO904378D0 true NO904378D0 (no) | 1990-10-10 |
| NO904378L NO904378L (no) | 1991-10-01 |
| NO179044B NO179044B (no) | 1996-04-15 |
| NO179044C NO179044C (no) | 1996-07-24 |
Family
ID=13738789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO904378A NO179044C (no) | 1990-03-30 | 1990-10-10 | Fremgangsmåte for fremstilling av et glykosaminoglykanmodifisert protein |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5310881A (no) |
| EP (1) | EP0454898B1 (no) |
| JP (1) | JP2975632B2 (no) |
| KR (1) | KR100188382B1 (no) |
| AT (1) | ATE135375T1 (no) |
| AU (1) | AU649416B2 (no) |
| CA (1) | CA2027447A1 (no) |
| DE (1) | DE69025920T2 (no) |
| DK (1) | DK0454898T3 (no) |
| ES (1) | ES2083989T3 (no) |
| FI (1) | FI102836B1 (no) |
| NO (1) | NO179044C (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69201066T2 (de) * | 1991-03-07 | 1995-05-11 | Kanto Ishi Pharma Co Ltd | Colominsäure und Produkte einer teilweisen Hydrolyse von Colominsäure zur Herstellung von Arzneimitteln zur Behandlung von Hepatitis, Nephritis und Arthritis. |
| GB9112212D0 (en) * | 1991-06-06 | 1991-07-24 | Gregoriadis Gregory | Pharmaceutical compositions |
| US5846951A (en) * | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
| GB2266239B (en) * | 1992-03-25 | 1996-03-06 | Jevco Ltd | Wound healing compositions containing chondroitin sulphate oligosaccharides |
| CA2091544A1 (en) * | 1992-03-26 | 1993-09-27 | Shing F. Kwan | Stabilization of functional proteins |
| ES2312166T3 (es) * | 1994-02-23 | 2009-02-16 | Kyowa Hakko Kogyo Co., Ltd | Acelerador del crecimiento plaquetario. |
| AU6926194A (en) * | 1994-05-09 | 1995-11-29 | Boehringer Mannheim Gmbh | Use of chondroitin sulphate proteoglycans for protection of neurons |
| US6228998B1 (en) | 1994-07-22 | 2001-05-08 | Seikagaku Kogyo Kabushiki Kaisha | Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide |
| PT789590E (pt) * | 1994-09-23 | 2002-12-31 | Zonagen Inc | Imunopotenciacao induzida por quitosano |
| US5912000A (en) * | 1994-09-23 | 1999-06-15 | Zonagen, Inc. | Chitosan induced immunopotentiation |
| US5677276A (en) * | 1994-12-23 | 1997-10-14 | La Jolla Cancer Research Foundation | Immobilization of peptides to hyaluronate |
| CN1196734A (zh) * | 1995-09-19 | 1998-10-21 | 生化学工业株式会社 | 消炎药 |
| US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
| US6562781B1 (en) * | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US6491965B1 (en) * | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| CA2266747A1 (en) * | 1996-09-25 | 1998-04-02 | Mary Ann Childs | Diagnostic test devices with improved fluid movement and resistance to interferences |
| WO2001005434A2 (en) * | 1999-07-20 | 2001-01-25 | Amgen Inc. | Hyaluronic acid-protein conjugates |
| ES2466024T3 (es) * | 2001-10-10 | 2014-06-09 | Ratiopharm Gmbh | Remodelación y glicoconjugación de factor de crecimiento de fibroblastos (FGF) |
| DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
| DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| BR0314107A (pt) | 2002-09-11 | 2005-07-19 | Fresenius Kabi De Gmbh | Método de produção de derivados de hidroxialquil amido |
| US8673333B2 (en) * | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
| US7862831B2 (en) * | 2002-10-09 | 2011-01-04 | Synthasome, Inc. | Method and material for enhanced tissue-biomaterial integration |
| EP1558216A4 (en) * | 2002-09-25 | 2007-01-03 | Univ Johns Hopkins Med | NETWORKED POLYMER MATRICES AND MANUFACTURING AND USE METHOD THEREFOR |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| WO2005016974A1 (en) * | 2003-08-12 | 2005-02-24 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
| WO2006089119A2 (en) * | 2005-02-18 | 2006-08-24 | Cartilix, Inc. | Biological adhesive |
| JP2008531764A (ja) | 2005-02-23 | 2008-08-14 | リポクセン テクノロジーズ リミテッド | タンパク質の誘導体化及び結合のための活性化シアル酸誘導体 |
| EP1886696A1 (en) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
| US8658593B2 (en) | 2011-06-06 | 2014-02-25 | The Cleveland Clinic Foundation | Treatment of extracellular matrix to reduce inflammation |
| WO2015046602A1 (ja) | 2013-09-30 | 2015-04-02 | 生化学工業株式会社 | タンパク質の血中滞留性の増強方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2824092A (en) * | 1955-01-04 | 1958-02-18 | Robert E Thompson | Process of preparation of a gelatincarboxymethyl cellulose complex |
| GB1479268A (en) * | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
| US4301153A (en) * | 1977-03-21 | 1981-11-17 | Riker Laboratories, Inc. | Heparin preparation |
| CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
| US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| NL188622C (nl) * | 1981-12-15 | 1992-08-17 | Cordis Europ | Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film. |
| US4526714A (en) * | 1982-12-13 | 1985-07-02 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
| SE8200751L (sv) * | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
| US4585754A (en) * | 1984-01-09 | 1986-04-29 | Valcor Scientific, Ltd. | Stabilization of proteins and peptides by chemical binding with chondroitin |
| US4863907A (en) * | 1984-06-29 | 1989-09-05 | Seikagaku Kogyo Co., Ltd. | Crosslinked glycosaminoglycans and their use |
| DE3680524D1 (de) * | 1986-04-22 | 1991-08-29 | Valcor Scient Ltd | Verfahren zur stabilisierung von proteinen. |
| US4745180A (en) * | 1986-06-27 | 1988-05-17 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using heparin fragments |
| DE3636590A1 (de) * | 1986-10-28 | 1988-05-26 | Braun Melsungen Ag | Blutersatzmittel |
| FR2631970B1 (fr) * | 1988-05-24 | 1993-12-24 | Sanofi | N-polyosyl-polypeptides |
| DE3819079A1 (de) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | Hirudin-derivate mit verzoegerter wirkung |
| US5023078A (en) * | 1988-08-10 | 1991-06-11 | Albert P. Halluin | Plasminogen activator-heparin conjugates |
| JP2766303B2 (ja) | 1989-04-13 | 1998-06-18 | 生化学工業株式会社 | グリコサミノグリカンで修飾されたスーパーオキシドジスムターゼ及びその製造法 |
-
1990
- 1990-03-30 JP JP2081163A patent/JP2975632B2/ja not_active Expired - Lifetime
- 1990-10-10 NO NO904378A patent/NO179044C/no unknown
- 1990-10-10 AU AU64506/90A patent/AU649416B2/en not_active Ceased
- 1990-10-11 FI FI905003A patent/FI102836B1/fi not_active IP Right Cessation
- 1990-10-12 KR KR1019900016160A patent/KR100188382B1/ko not_active Expired - Fee Related
- 1990-10-12 DK DK90119607.1T patent/DK0454898T3/da active
- 1990-10-12 ES ES90119607T patent/ES2083989T3/es not_active Expired - Lifetime
- 1990-10-12 CA CA002027447A patent/CA2027447A1/en not_active Abandoned
- 1990-10-12 EP EP90119607A patent/EP0454898B1/en not_active Expired - Lifetime
- 1990-10-12 AT AT90119607T patent/ATE135375T1/de active
- 1990-10-12 DE DE69025920T patent/DE69025920T2/de not_active Expired - Fee Related
-
1992
- 1992-07-02 US US07/908,910 patent/US5310881A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE135375T1 (de) | 1996-03-15 |
| DE69025920D1 (de) | 1996-04-18 |
| CA2027447A1 (en) | 1991-10-01 |
| KR910016770A (ko) | 1991-11-05 |
| AU649416B2 (en) | 1994-05-26 |
| NO904378L (no) | 1991-10-01 |
| ES2083989T3 (es) | 1996-05-01 |
| KR100188382B1 (ko) | 1999-06-01 |
| NO179044C (no) | 1996-07-24 |
| FI102836B (fi) | 1999-02-26 |
| EP0454898B1 (en) | 1996-03-13 |
| DK0454898T3 (da) | 1996-04-15 |
| JPH03284698A (ja) | 1991-12-16 |
| US5310881A (en) | 1994-05-10 |
| NO179044B (no) | 1996-04-15 |
| JP2975632B2 (ja) | 1999-11-10 |
| AU6450690A (en) | 1991-10-31 |
| DE69025920T2 (de) | 1996-08-14 |
| FI905003L (fi) | 1991-10-01 |
| EP0454898A1 (en) | 1991-11-06 |
| FI102836B1 (fi) | 1999-02-26 |
| FI905003A0 (fi) | 1990-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904378L (no) | Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse. | |
| NO875299D0 (no) | Insulinpreparat for ikke-paranteral administrasjon. | |
| NO882732D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| YU174490A (sh) | Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja | |
| DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
| ATA260690A (de) | Therapeutische infusionszubereitung auf basis von aminosäurederivaten | |
| DE68910377D1 (de) | Kosmetisches Präparat. | |
| NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| FI885807L (fi) | Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen | |
| FR2623806B1 (fr) | Esters d'acides 3,6-dihydro-1,5(2h)-pyrimidinecarboxyliques a action therapeutique | |
| NO870049D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| IL91184A0 (en) | N-2,3-butadienyl tri-and tetraaminoalkane derivatives | |
| BG44709A3 (bg) | Метод за получаване на 9-хлор-1,5-бензотиазепинови производни | |
| ZA883744B (en) | Promotion of healing of meniscal tissue | |
| DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
| DE59009378D1 (de) | Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung. | |
| FI891210A7 (fi) | Tiosulfiinihappojohdannaiset, niiden käyttö tulehdussairauksien käsitt elyyn sekä näitä aineita sisältävät lääkeaineet | |
| DE3784048D1 (de) | 5-hydroxymethyl-derivate des 2-oxazolidinons, deren herstellung und deren anwendung in der therapie. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| DE3876425D1 (de) | Gesteuerte verabreichung eines heilmittels an blut. | |
| JPS6438073A (en) | Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition | |
| DK576687D0 (da) | Terapeutisk aktive alkensyrederivater | |
| NO880639D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner. | |
| NO883699L (no) | Haarbehandlingsmiddel med et innhold av d,l-mandelsyre. |